Cargando…

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

The antibiotic pipeline continues to diminish and the majority of the public remains unaware of this critical situation. The cause of the decline of antibiotic development is multifactorial and currently most ICUs are confronted with the challenge of multidrug-resistant organisms. Antimicrobial mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassetti, Matteo, De Waele, Jan J., Eggimann, Philippe, Garnacho-Montero, Josè, Kahlmeter, Gunnar, Menichetti, Francesco, Nicolau, David P., Paiva, Jose Arturo, Tumbarello, Mario, Welte, Tobias, Wilcox, Mark, Zahar, Jean Ralph, Poulakou, Garyphallia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080151/ https://www.ncbi.nlm.nih.gov/pubmed/25792203 http://dx.doi.org/10.1007/s00134-015-3719-z

Ejemplares similares

Principles of antimicrobial stewardship for bacterial and fungal infections in ICU
por: Bassetti, Matteo, et al.
Publicado: (2017)

Planet’s population on the move, infections on the rise
por: Poulakou, Garyphallia, et al.
Publicado: (2016)

Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?
por: Dimopoulos, George, et al.
Publicado: (2023)

A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!
por: Garnacho-Montero, Jose, et al.
Publicado: (2006)

Emerging and Re-Emerging Infectious Diseases: Humankind’s Companions and Competitors
por: Spernovasilis, Nikolaos, et al.
Publicado: (2022)

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
por: De Bus, Liesbet, et al.
Publicado: (2020)

European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria
por: Lepape, Alain, et al.
Publicado: (2020)

Less contact isolation is more in the ICU: pro
por: Poulakou, Garyphallia, et al.
Publicado: (2020)

Focus on infection
por: Martin-Loeches, Ignacio, et al.
Publicado: (2020)

Assessing the quality of the anaerobic environment — a method developed to support EUCAST disk diffusion of anaerobic bacteria
por: Justesen, Ulrik Stenz, et al.
Publicado: (2023)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Timing of antibiotic therapy in the ICU
por: Kollef, Marin H., et al.
Publicado: (2021)

Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?
por: Bassetti, Matteo, et al.
Publicado: (2016)

Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
por: Kollias, Anastasios, et al.
Publicado: (2021)

Dissemination of Multidrug-Resistant Bacteria into the Arctic
por: Sjölund, Maria, et al.
Publicado: (2008)

Defining antibiotic resistance-towards international harmonization
por: Kahlmeter, Gunnar
Publicado: (2014)

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic()
por: Estella, Ángel, et al.
Publicado: (2020)

Advances in antibiotic therapy in the critically ill
por: Vincent, Jean-Louis, et al.
Publicado: (2016)

High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can
por: Garnacho-Montero, José, et al.
Publicado: (2014)

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
por: De Waele, Jan J., et al.
Publicado: (2020)

24th International Symposium on Infections in the Critically Ill Patient
por: Artigas, Antonio, et al.
Publicado: (2019)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Practical approach to the management of catheter-related bloodstream infection
por: Cantón-Bulnes, Mª Luisa, et al.
Publicado: (2019)

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome
por: Garnacho-Montero, José, et al.
Publicado: (2005)

Preventing the next 'SARS' - European healthcare workers' attitudes towards monitoring their health for the surveillance of newly emerging infections: qualitative study
por: Aghaizu, Adamma, et al.
Publicado: (2011)

Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper(#)
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2020)

Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis
por: Garnacho-Montero, Jose, et al.
Publicado: (2006)

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008
por: Kahlmeter, Gunnar, et al.
Publicado: (2015)

The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles
por: Jonasson, Emma, et al.
Publicado: (2020)

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients
por: Hatzaki, Despina, et al.
Publicado: (2012)

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later
por: Eggimann, Philippe, et al.
Publicado: (2014)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

New antibiotics for the treatment of nonfermenting Gram-negative bacteria
por: Bassetti, Matteo, et al.
Publicado: (2021)

Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

ICU-Associated Gram-Negative Bloodstream Infection: Risk Factors Affecting the Outcome Following the Emergence of Colistin-Resistant Isolates in a Regional Greek Hospital
por: Karvouniaris, Marios, et al.
Publicado: (2022)

Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections
por: Fernández-Galilea, Adela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jf3ki9aev7aac7k5k5pko5fmc